Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

AsymmetRx Medical

2001 FOUNDED
PRIVATE STATUS
Accelerator/Inc LATEST DEAL TYPE
1 INVESTORS
Description

Developer of drug and medical devices. The company has developed p63 gene which is involved in the diagnosis of prostate cancer and many other cancers.

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Drug Discovery
Other Industries
Other Devices and Supplies
Other Healthcare Services
Primary Office
  • 100 Powder Mill Road
  • Suite 177
  • Acton, MA 01720
  • United States

+1 (617) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore AsymmetRx Medical’s full profile, request a free trial.

AsymmetRx Medical Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

AsymmetRx Medical Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Johns Hopkins Technology Ventures Accelerator/Incubator 000 0000 000000 0

AsymmetRx Medical Executive Team (4)

Name Title Board
Seat
Contact
Info
Peter McKeon President & Board Member
Frank McKeon Ph.D Executive
Matthew Vincent Ph.D Executive

1 Former Executive

You’re viewing 3 of 4 executives. Get the full list »

AsymmetRx Medical Board Members (1)

Name Representing Role Since Contact
Info
Peter McKeon AsymmetRx Medical President & Board Member 000 0000